Hyperion Therapeutics Gets $15M In Debt
South San Francisco-based biopharmaceuticals firm Hyperion Therapeutics said Thursday that the firm has raised $15M in debt financing. The funding came from Comerica Bank, and also came in conjunction with a new executive team. Hyperion said that it has added Marvin Garovoy, M.D. as SVP Clinical Development; Sharron Gargosky, Ph.D. as Chief Scientific Officer and SVP Corporate Development; Klara Dickinson as SVP Regulatory Affairs and Compliance; Kevin Weber as SVP Global Strategy and Operatoins; Wayne Davis, Ph.D. as VP Clinical Operations; Hoi Leung, Ph.D. as VP Biostatistics; George Jue as VP Finance and Controller; and James Kaser as VP Global Sales.
posted on Friday, October 5, 2007
Related companies:
Hyperion
Related stories:
> Hyperion Therapeutics Gets $40M
> Hyperion Therapeutics Raises $60M
> Hyperion Therapeutics Files For IPO
> Hyperion Acquires Decisioneering
> Oracle Buys Hyperion For $3.3B
silicontap.com Home